leadf
logo-loader
viewPolar Capital Global Healthcare Trust PLC

Polar Capital Global Healthcare's David Pinniger on the outlook for biotech opportunities

Polar Capital Global Healthcare Trust's (LON:PCGH) David Pinniger discusses what opportunities there are for investors within the biotech space and what the next decade may hold for the sector.

''Investors tend to think biotech is a purely US-centric industry and to a certain degree that's true … but we are beginning to see a significant number of exciting new opportunities come through in Europe''.
 

Quick facts: Polar Capital Global Healthcare Trust PLC

Price: 244 GBX

LSE:PCGH
Market: LSE
Market Cap: £295.9 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Polar Capital Global Healthcare Trust PLC named herein, including the promotion by the Company of Polar Capital Global Healthcare Trust PLC in...

FOR OUR FULL DISCLAIMER CLICK HERE

Polar Capital upbeat on the outlook for the healthcare sector

According to James Douglas, fund manager of Polar Capital Global Healthcare Trust PLC (LON:PCGH), the US election isn’t affecting market sentiment in his sector quite as much as it has. Douglas, together with his team reckon valuations for the drug and device makers and care...

on 23/1/20

2 min read